<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan's syndrome</z:e> is a <z:e sem="disease" ids="C0019247" disease_type="Disease or Syndrome" abbrv="">genetic disorder</z:e> affecting connective tissues, and it can lead to <z:hpo ids='HP_0011420'>death</z:hpo> due to aortic defects if left untreated </plain></SENT>
<SENT sid="1" pm="."><plain>beta-blocker therapy has been used to slow the progression of this disease </plain></SENT>
<SENT sid="2" pm="."><plain>Brooke et al </plain></SENT>
<SENT sid="3" pm="."><plain>(2008) now report that combining <z:chebi fb="0" ids="2719,48432">angiotensin II</z:chebi> receptor blockade by <z:chebi fb="0" ids="6541">losartan</z:chebi> with beta-blocker treatment is an effective treatment combination therapy for this disorder </plain></SENT>
</text></document>